机译:氯化钠通过诱导致病性TH17细胞来驱动自身免疫性疾病
Departments of Neurology and Immunobiology, Yale School of Medicine, 15 York Street, New Haven, Connecticut 06520, USA,Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA;
department of Neurology, University of Erlangen-Nuremberg, Schwabachanlage 6,91054 Erlangen, Germany,International Graduate School of Neuroscience, Ruhr-University Bochum, Universitatsstr, 150,44801 Bochum, Germany;
Division of Clinical Pharmacology, Vanderbilt University, 2213 Garland Avenue, Nashville, Tennessee 37232, USA,Interdisciplinary Center for Clinical Research and Department for Nephrology and Hypertension, University of Erlangen-Nuremberg, Glueckstr. 6,91054 Erlangen, Germany;
Experimental and Clinical Research Center, a joint cooperation between the Charite Medical Faculty and the Max-Delbruck Center for Molecular Medicine, Lindenberger Weg80,13125 Berlin, Germany,Helios Klinikum Berlin-Buch, Schwanebecker Chaussee 50,13125 Berlin, Germany;
Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA;
department of Neurology, University of Erlangen-Nuremberg, Schwabachanlage 6,91054 Erlangen, Germany;
Experimental and Clinical Research Center, a joint cooperation between the Charite Medical Faculty and the Max-Delbruck Center for Molecular Medicine, Lindenberger Weg80,13125 Berlin, Germany,Nikolaus-Fiebiger-Center for Molecular Medicine, University of Erlangen-Nuremberg, Gluckstr. 6, 91054 Erlangen, Germany;
Departments of Neurology and Immunobiology, Yale School of Medicine, 15 York Street, New Haven, Connecticut 06520, USA,Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA;
机译:自身免疫疾病致病性Th17细胞的分子控制
机译:自身免疫疾病致病性Th17细胞的分子控制
机译:自身免疫疾病中Th17细胞的致病性(Vol 41,PG 283,2019)
机译:HL161,一种新型抗FCRN抗体,作为致病IgG介导的自身免疫疾病的新治疗选择
机译:CD4 T细胞在自身免疫性疾病中的致病潜力。
机译:氯化钠驱动自身免疫疾病病原的Th17细胞的诱导
机译:氯化钠通过诱导致病性TH17细胞来驱动自身免疫性疾病